Biologic Response Modifiers Market by Product Type (Interleukins, Interferons, Colony stimulating factors, Tyrosine kinase inhibitors, TNF-α, Angiogenic Inhibitors, Monoclonal antibodies, Tumor Vaccines) by Treatment Type (Cancer, Autoimmune Diseases) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies): Growth, Future Prospects, and Competitive Analysis, 2015 - 2027

Makret Insights:

Biologic Response Modifiers are immunomodulators that modify immune responses. These substances can enhance or suppress the immune response. A few biological response modifiers include interferons, interleukins, colony-stimulating factors, monoclonal antibodies, and tumor necrosis, amongst others. These immunomodulators are used in cancer biotherapy to defend the body against infection, disease, and cancer. The revenue generated by the global Biologic Response Modifiers market was valued at around USD 135.3 billion in 2020 and is expected to account for USD 150.2 billion, growing at a CAGR of 5.4% during the forecast timeline.

Biologic Response Modifiers Market

To learn how our report can help you streamline your business, Request Sample Here


Increasing Prevalence of Cancer Across the Globe

Biologic Response Modifiers are mainly used in the treatment of cancer. Biologic Response Modifiers help fight against cancer cells by strengthening the immune system. The increasing prevalence of cancer is fueling the demand for Biologic Response Modifiers around the globe. In 2020, around 1.8 million were found with cancer across the world. The total number of people who have cancer will reach up to 1.4% of the entire population in 2020. While, conditions in the U.S. is worst, with 5.5% of the entire population suffering from cancer as of 2020. Similarly, Australia, New Zealand, Ireland, Hungary, France, the U.K., South Korea, etc., are some countries with a notable prevalence rate of cancer. 

However, high costs and lack of market penetration are holding back the growth of this industry. Emerging countries with limited access to the latest treatments and drugs, lack of healthcare infrastructure, unfavorable or absence of insurance policy, low spending power, etc., are some of the other key factors expected to contribute to the low growth rate of Biologic Response Modifiers industry.

The outbreak of COVID 19 and its Consequences

COVID 19 has positively impacted the global Biologic Response Modifiers industry. The demand for immunity enhancers increased during the pandemic outbreak. This led to an outrageous rise in sales of biologic response modifiers medicines. Moreover, due to the demand for biological response modifiers, the market players are investing a huge amount in research and development activities. The industry players are introducing advanced medications to enhance the patients' immunity. Such factors are propelling the demand for biologic response modifiers that will further fuel the market growth in the forecast timeline.

The U.S. Topped in Demand for Biologic Response Modifiers 

The U.S. is a major force behind the growth of the Biologic Response Modifiers market. First, this can be mainly attributed to the widespread network of healthcare facilities and deep routed distribution networks of leading healthcare companies in the country. Secondly, the higher prevalence of cancer owing to changing lifestyles, the higher spending power of patients, favorable reimbursement policies, strong expenditure by the government on healthcare policies, etc., has resulted in higher demand for Biologic Response Modifiers in the U.S.  

Cancer Treatment Will Held the Major Share

Cancer treatment is dominating the global Biologic Response Modifiers market with over 60% share in total revenue generation in 2020. The highest share of cancer treatment in the Biologic Response Modifiers industry can be attributed to a higher prevalence rate of cancer in the U.S. and the world. However, autoimmune diseases are also expected to hold a considerable share in the overall revenue generation of the Biologic Response Modifiers industry. More than 7% of the United States population is suffering from one type of autoimmune disease. Furthermore, there are over 80 types of diseases in the family of the autoimmune disease. With the rising incidence of the aforementioned disease, the demand for Biologic Response Modifiers is expected to gear up over the forecast period.

Retail Pharmacies Will Occupy Largest Chunk of Global Market

The Global Biologic Response Modifiers market is segmented based on distribution channels such as Retail Pharmacies, Hospital Pharmacies, and Mail Order Pharmacies. The rising establishment of organized retail players is propelling the sales of biologic response modifiers through the retail pharmacy channels. As a result, the retail pharmacy is expected to grow at a CAGR of 10.06% during the analysis period. Some of the leading players involved in this industry include Novartis, Janssen Inc., Roche Holding AG, Merck & Co., and Eli Lilly & Co. All major players are focusing on extensive R&D.

 Frequently asked questions about the market

Unlike other industries, COVID 19 has positive impact on Biologic Response Modifiers industry. The reason being use of Biologic Response Modifiers in treatment of COVID 19 patients.

Some of the leading players in the global BMR industry include but not limited to Novartis, Janssen Inc., Roche Holding AG, Merck & Co. and Eli Lilly & Co.

Cancer treatment is leading the global Biologic Response Modifiers industry with highest share in total revenue generation in 2020

U.S. is the single largest market for the Biologic Response Modifiers industry with over 25% share in total market value. Dominance of U.S. is a result of multiple factors such as higher health awareness, strong government expenditure on healthcare and ease of access to all innovative treatments owing presence of leading Biologic Response Modifiers companies in the country

The global Biologic Response Modifiers market report is expected to exhibit CAGR of around 5.4% from 2021 to 2027

Choose License Type
Trusted By
Related Report

Published Date:  Apr 2021
Category:  Medical Devices
Report ID:   60318
Report Format:   PDF
Pages:   120
Rating:    4.3 (56)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support